TITLE

Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes

AUTHOR(S)
WEI-DONG WANG; LIN XING; JUN-RU TENG; SHUO LI; NA MI
PUB. DATE
June 2015
SOURCE
Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 6, p2219
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of this study was to investigate the effects of basal insulin application on the serum visfatin and adiponectin (APN) levels of patients with type 2 diabetes mellitus (T2DM). A total of 200 patients with T2DM, who were diagnosed in The Third People's Hospital of Jinan (glycosylated hemoglobin ≥7%), were randomly divided into treatment and control groups. The patients used only oral hypoglycemic drugs and had never received insulin therapy. In the treatment group, basal insulin was administered in combination with the original application of oral hypoglycemic drugs, whereas the control group maintained the original use of oral hypoglycemic drugs or took other oral hypoglycemic agents. The body mass index and fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, visfatin, APN and blood lipid levels of the patients were examined prior to the treatment and six months later. The drug and insulin doses in the treatment group were adjusted according to the patients' blood glucose, which allowed the fasting and postprandial blood glucose levels to attain the standards. The fasting and postprandial blood glucose levels in the control group also achieved the standards. It was found that the six-month application of basal insulin could significantly decrease the glycosylated hemoglobin and significantly increase the serum APN levels; the serum visfatin levels, however, remained unchanged. The immediate application of basal insulin could facilitate the attainment of glycosylated hemoglobin standards in T2DM and could increase the plasma APN levels, preventing diabetic vascular complications.
ACCESSION #
103242209

 

Related Articles

  • Microbiota and diabetes: an evolving relationship. Tilg, Herbert; Moschen, Alexander R. // Gut;Sep2014, Vol. 63 Issue 9, p1513 

    The gut microbiota affects numerous biological functions throughout the body and its characterisation has become a major research area in biomedicine. Recent studies have suggested that gut bacteria play a fundamental role in diseases such as obesity, diabetes and cardiovascular disease. Data...

  • Urinary patterns analysis of type 2 diabetes mellitus patients by nuclear magnetic resonance spectroscopy method (1H-NMR). Stefan, L. I.; Nicolescu, A.; Sandu, M.; Popa, G. S.; Moţa, M.; Deleanu, C. // Biochemia Medica;2014 Supplement, Vol. 24, pS61 

    Background: Proton nuclear magnetic resonance spectroscopy method (1H-NMR) was applied to investigate the urinary patterns of type 2 diabetes mellitus (T2DM) patients to identify possible disturbances that may accompany T2DM. We investigate the potential relationship between diabetic retinopathy...

  • In the news.  // African Journal of Diabetes Medicine;Nov2014, Vol. 22 Issue 2, p4 

    The article offers medical news briefs as of November 2, 2014. French global telecommunications equipment company Alcatel- Lucent is supporting the Senegalese government. A study on type-1 diabetes shows that it is possible to make vast quantities of insulinproducing cells for patient...

  • Preliminary analysis of immune activation in early onset type 2 diabetes. Rempel, Julia D.; Packiasamy, Juliet; Dean, Heather J.; McGavock, Jonathon; Janke, Alyssa; Collister, Mark; Wicklow, Brandy; Sellers, Elizabeth A. C. // Circumpolar Health Supplements;2013 Supplement 1, Vol. 72, p293 

    Introduction. First Nations and other Aboriginal children are disproportionately affected by cardiometabolic diseases, including type 2 diabetes (T2D). In T2D, the disruption of insulin signalling can be driven by proinflammatory immunity. Pro-inflammatory responses can be fueled by toll-like...

  • Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation. Wu, Jie; Wu, Jun-jie; Yang, Lin-jun; Wei, Li-xin; Zou, Da-jin // Endocrine (1355008X);Aug2013, Vol. 44 Issue 1, p87 

    Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes. Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is found to have a protective effect on islet beta-cell. To date, the mechanism underlying the protective role...

  • Left Ventricular Diastolic Dysfunction (LVDD) & Cardiovascular Autonomic Neuropathy (CAN) in Type 2 Diabetes Mellitus (DM): A Cross-Sectional Clinical Study. MYTHRI, S.; RAJEEV, H. // Journal of Clinical & Diagnostic Research;Jan2015, Vol. 9 Issue 1, p18 

    Introduction: Cardiovascular autonomic neuropathy (CAN) is one of the major complications of Diabetes Mellitus (DM) seen in a significant number of patients, which is often ignored and is also least frequently diagnosed. It can be diagnosed by performing five standard non-invasive bedside...

  • Patient profiling in diabetes and role of canagliflozin. Amblee, Ambika // Pharmacogenomics & Personalized Medicine;2014, Vol. 7, p367 

    Background: Physicians attempt to achieve glycemic goals in patients with type 2 diabetes mellitus (T2DM) through various means, including glucose-lowering medications. There is interindividual variability in response to medications, which can be partially explained by the presence of genetic...

  • CLINICAL UTILITY OF CORONARY CALCIUM SCORING IN DIABETIC PATIENTS WITH NORMAL OR MILD ISCHEMIA IN MYOCARDIAL PERFUSION SCINTIGRAPHY. El-Guindy, Amr; Nassar, Ahmed; El-Rahman, Ahmed Abd; Aziz, Mohamed Abdel // International Journal of Academic Research;Nov2011, Vol. 3 Issue 6, p249 

    Background: Diabetic patients have a high prevalence of coronary atherosclerosis, once CAD is manifested clinically; diabetic patients continue to have a worse prognosis compared with non-diabetic patients both acutely after the event and during long-term follow-up. So detection of coronary...

  • High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. Hadaegh, Farzad; Bozorgmanesh, Mohammad Reza; Ghasemi, Asghar; Harati, Hadi; Saadat, Navid; Azizi, Fereidoun // BMC Public Health;2008, Vol. 8 Issue 1, p176 

    Background: To estimate the prevalence of diagnosed and undiagnosed diabetes mellitus, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and combined IFG/IGT in a large urban Iranian population aged ⩾ 20 years. Methods: The study population included 9,489 participants of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics